Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>FL R/R>*** > TREAT.: > USA. G. CAR T Therapy>



USA. G. CAR T Therapy>'s subsections
(*) CN Approval Date: 2021. 06.23
(*) EU CE Mark Date: 2022. 06.28
(*) USA Approval Date: 2021. 03.05
>2-3 Systemic Therapies
Company
Company CN
Generic Name:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 03.09
TradeMark
TradeMark Web-Site

USA. G. CAR T Therapy>'s products
This section has no products